Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Acasti Pharma Inc. Discusses Year-End Results and Clinical Development Progress with The Stock Day Podcast
      Biotech

      Acasti Pharma Inc. Discusses Year-End Results and Clinical Development Progress with The Stock Day Podcast

      July 25, 2022
      Hoth Therapeutics Announces HT-ALZ Therapeutic Shows Cognitive Improvements in Alzheimer’s Disease Mouse Model
      Biotech

      Hoth Therapeutics Announces HT-ALZ Therapeutic Shows Cognitive Improvements in Alzheimer’s Disease Mouse Model

      July 25, 2022
      REGENXBIO Announces Enrollment Complete in Cohort 5 of Phase II AAVIATE® Trial
      Biotech

      REGENXBIO Announces Enrollment Complete in Cohort 5 of Phase II AAVIATE® Trial

      July 25, 2022
      Immunocore announces dosing of first patient with ImmTAV® bispecific for HIV
      Biotech

      Immunocore announces dosing of first patient with ImmTAV® bispecific for HIV

      July 25, 2022
      Arcutis Biotherapeutics Reaches Regulatory Milestone with Health Canada Acceptance of New Drug Submission for Roflumilast Cream for Adults and Adolescents with Plaque Psoriasis
      Biotech

      Arcutis Biotherapeutics Reaches Regulatory Milestone with Health Canada Acceptance of New Drug Submission for Roflumilast Cream for Adults and Adolescents with Plaque Psoriasis

      July 25, 2022
      Pluristem Reports Topline Results from its Phase III Study of Muscle Regeneration Following Hip Fracture Surgery
      Biotech

      Pluristem Reports Topline Results from its Phase III Study of Muscle Regeneration Following Hip Fracture Surgery

      July 25, 2022
      Histogen Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
      Biotech

      Histogen Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

      July 25, 2022
      Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
      Biotech

      Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      July 25, 2022
      Vaxcyte Completes Enrollment of Phase 2 Portion of Phase 1/2 Clinical Proof-of-Concept Study Evaluating Safety, Tolerability and Immunogenicity of VAX-24 in Adults
      Biotech

      Vaxcyte Completes Enrollment of Phase 2 Portion of Phase 1/2 Clinical Proof-of-Concept Study Evaluating Safety, Tolerability and Immunogenicity of VAX-24 in Adults

      July 25, 2022
      The GBT Foundation Awards $250,000 in ACE Grants to Support Sickle Cell Disease Community-Based Organizations
      Biotech

      The GBT Foundation Awards $250,000 in ACE Grants to Support Sickle Cell Disease Community-Based Organizations

      July 25, 2022
      « 1 … 128 129 130 131 132 … 138 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026